Inventor
PEPINSKY R BLAKE
US51 patents
⚠️ This page may combine multiple inventors who share the name “PEPINSKY R BLAKE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BIOGEN INC
13 patentsUS5804604ASep 8, 1998
Tat-derived transport polypeptides and fusion proteins
BIOGEN INC470 citations98
US5747641AMay 5, 1998
Tat-derived transport polypeptide conjugates
BIOGEN INC319 citations98
US5674980AOct 7, 1997
Fusion protein comprising tat-derived transport moiety
BIOGEN INC349 citations98
US5670617ASep 23, 1997
Nucleic acid conjugates of tat-derived transport polypeptides
BIOGEN INC189 citations98
US5545723AAug 13, 1996
Muteins of IFN-β
BIOGEN INC60 citations94
US4879224ANov 7, 1989
DNA sequences, recombinant DNA molecules and processes for producing human phospholipase inhibitor polypeptides
BIOGEN INC44 citations92
US6127332AOct 3, 2000
Muteins of IFN-β
BIOGEN INC27 citations90
US5484711AJan 16, 1996
DNA sequences, recombinant DNA molecules and processes for producing lipocortins III, IV, V & VI
BIOGEN INC18 citations82
US5298489AMar 29, 1994
DNA sequences recombinant DNA molecules and processes for producing lipocortins III, IV, V and VI
BIOGEN INC8 citations74
US5081019AJan 14, 1992
DNA sequences, recombinant DNA molecules and processes for producing lipocortin-like polypeptides
BIOGEN INC14 citations74
US4874743AOct 17, 1989
DNA sequences, recombinant DNA molecules and processes for producing human phospholipase inhibitor-like polypeptides
BIOGEN INC13 citations74
US5359033AOct 25, 1994
Cleaved dimers of mullerian inhibiting substance-like polypeptides
BIOGEN INC12 citations73
US4950646AAug 21, 1990
DNA sequences, recombinant DNA molecules and processes for producing human lipocortin-like polypeptides
BIOGEN INC14 citations70
BIOGEN IDEC INC
11 patentsUS9066984B2Jun 30, 2015
Sp35 antibodies and uses thereof
BIOGEN IDEC INC26 citations92
US7785829B2Aug 31, 2010
Nogo receptor binding protein
BIOGEN IDEC INC15 citations92
US7442370B2Oct 28, 2008
Polymer conjugates of mutated neublastin
BIOGEN IDEC INC35 citations91
US6897297B1May 24, 2005
Hydrophobically-modified protein compositions and methods
BIOGEN IDEC INC21 citations91
US8894999B2Nov 25, 2014
Use of DR6 and p75 antagonists to promote survival of cells of the nervous system
BIOGEN IDEC INC10 citations83
US7196112B2Mar 27, 2007
Cell adhesion inhibitors
BIOGEN IDEC INC4 citations63
US8932821B2Jan 13, 2015
NOGO receptor binding protein
BIOGEN IDEC INC3 citations62
US9228015B2Jan 5, 2016
Nogo receptor antagonists and methods of increasing neurite outgrowth
BIOGEN IDEC INC2 citations61
US8017733B2Sep 13, 2011
Polyalkylene polymer compounds and uses thereof
BIOGEN IDEC INC4 citations56
US9068992B2Jun 30, 2015
Screening methods for identifying Sp35 antagonists
BIOGEN IDEC INC1 citations52
US8969042B2Mar 3, 2015
Refolding transforming growth factor beta family proteins
BIOGEN IDEC INC0 citations48
MI SHA
9 patentsUS8425910B2Apr 23, 2013
Composition comprising antibodies to LINGO or fragments thereof
MI SHA44 citations97
US8058406B2Nov 15, 2011
Composition comprising antibodies to LINGO or fragments thereof
MI SHA48 citations97
US8551476B2Oct 8, 2013
SP35 antibodies and uses thereof
MI SHA34 citations92
US8153580B2Apr 10, 2012
Nogo receptor binding protein
MI SHA17 citations92
US8128926B2Mar 6, 2012
Sp35 antibodies and uses thereof
MI SHA29 citations91
US8765662B2Jul 1, 2014
NOGO receptor binding protein
MI SHA6 citations84
US8486893B2Jul 16, 2013
Treatment of conditions involving demyelination
MI SHA8 citations84
US8609407B2Dec 17, 2013
Sp35 antibodies and uses thereof
MI SHA6 citations82
US8501178B2Aug 6, 2013
Use of DR6 and p75 antagonists to promote survival of cells of the nervous system
MI SHA7 citations82
BIOGEN MA INC
4 patentsUS9745375B2Aug 29, 2017
Compositions comprising antibodies to LINGO or fragments thereof
BIOGEN MA INC1 citations63
US10308706B2Jun 4, 2019
Methods of preventing and removing trisulfide bonds
BIOGEN MA INC1 citations59
US11827702B2Nov 28, 2023
Anti-transferrin receptor antibodies and uses thereof
BIOGEN MA INC1 citations55
US9796780B2Oct 24, 2017
LINGO-2 antagonists for treatment of conditions involving motor neurons
BIOGEN MA INC1 citations52
SAH DINAH WEN-YEE
3 patentsUNIV YALE
2 patentsROSSOMANDO ANTHONY
2 patentsWHITEHEAD BIOMEDICAL INST
1 patent(unassigned)
1 patentCURIS INC
1 patentLEE DANIEL H S
1 patentWILLIAMS KEVIN
1 patentEVANS DAVID
1 patentShowing the top 50 of 51 patents by PatentIndex Score.